Addex Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Addex Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Addex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Addex Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Addex |
Addex Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Addex Therapeutics on October 14, 2025 and sell it today you would earn a total of 100.00 from holding Addex Therapeutics or generate -100.0% return on investment over 90 days. Addex Therapeutics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Addex, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Addex Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Addex Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Addex Therapeutics, and traders can use it to determine the average amount a Addex Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ADDXF |
Based on monthly moving average Addex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding Addex Therapeutics to a well-diversified portfolio.
Addex Therapeutics Fundamentals Growth
Addex OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Addex Therapeutics, and Addex Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Addex OTC Stock performance.
| Return On Equity | -2.03 | |||
| Return On Asset | -0.88 | |||
| Operating Margin | (17.07) % | |||
| Current Valuation | 35.5 M | |||
| Shares Outstanding | 26.37 M | |||
| Price To Earning | 48.86 X | |||
| Price To Sales | 25.73 X | |||
| Revenue | 1.25 M | |||
| EBITDA | (21.51 M) | |||
| Cash And Equivalents | 15.49 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 521.22 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (14.71 M) | |||
| Earnings Per Share | (0.54) X | |||
| Total Asset | 3 M | |||
| Retained Earnings | (279 M) | |||
| Current Asset | 3 M | |||
| Current Liabilities | 1000 K |
Things to note about Addex Therapeutics performance evaluation
Checking the ongoing alerts about Addex Therapeutics for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Addex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Addex Therapeutics is not yet fully synchronised with the market data | |
| Addex Therapeutics has some characteristics of a very speculative penny stock | |
| Addex Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.25 M. Net Loss for the year was (15.35 M) with loss before overhead, payroll, taxes, and interest of (9.69 M). | |
| Addex Therapeutics has accumulated about 15.49 M in cash with (14.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45. |
- Analyzing Addex Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Addex Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Addex Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Addex Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Addex Therapeutics' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Addex Therapeutics' otc stock. These opinions can provide insight into Addex Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Addex OTC Stock
If you are still planning to invest in Addex Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Addex Therapeutics' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |